PALS for Pap Smear Follow up

NCT ID: NCT04070534

Last Updated: 2025-08-15

Basic Information

• Recruitment Status: SUSPENDED
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-08-22
• Study Completion Date: 2026-12-31

Brief Summary

In this study, the researchers will utilize information gained from patient interviews about their knowledge of the cervical cancer screening and treatment process, and perceived barriers surrounding appropriate follow up, to create content for the intervention.

Detailed Description

The overall goal of this research is to develop and test an intervention designed to improve knowledge and follow up among underserved women with abnormal pap smears. The researchers will use a unique web-based platform, the Patient Activated Learning System (PALS), which provides engaging and informative video and text designed to improve patient knowledge specifically among underserved populations. Twenty diverse patients with abnormal pap smears will be recruited from the Women's Health colposcopy clinic for initial qualitative interviews. Forty patients from the same population will then be engaged in a pre-post pilot to examine feasibility, acceptability, and impact of modules on improving knowledge.

Conditions

Health Knowledge, Attitudes, Practice

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

PALS intervention

This arm will influence the development of a patient-directed education module using the Patient Activated Learning System (PALS)

Group Type: OTHER

PALS

Intervention Type: OTHER

patient activated learning system

Interventions

PALS

patient activated learning system

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• All Women 21-65 years with diagnosis of abnormal pap smear presenting to Women's Health Colposcopy Clinic at WCMC
• Access to a smartphone
• English or Spanish Speaking

Exclusion Criteria

• Pregnant women
• Non-English or Spanish speakers

• Minimum Eligible Age: 21 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

Weill Medical College of Cornell University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Eloise Chapman-Davis, MD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Locations

New York Prebyterian Hospital Weill Cornell

New York, New York, United States

Countries

United States

Other Identifiers

19-05020040

Identifier Type: -

Identifier Source: org_study_id